Vanda Pharmaceuticals (VNDA) Change in Acquisitions & Divestments (2010 - 2026)

Vanda Pharmaceuticals has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $30.5 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 65.26% year-over-year to $30.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $151.0 million (down 60.18% YoY) and the FY2025 annual result came in at $208.2 million, down 40.85% from the prior year.
• Change in Acquisitions & Divestments fell to $30.5 million in Q1 2026 per VNDA's latest filing, from $47.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $350.4 million in Q1 2023 and troughed at $30.5 million in Q1 2026.
• A 5-year average of $93.7 million and a median of $82.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments surged 289.0% in 2023, then sank 82.73% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $80.0 million in 2022, then soared by 40.14% to $112.1 million in 2023, then slipped by 13.83% to $96.6 million in 2024, then tumbled by 51.35% to $47.0 million in 2025, then plunged by 35.2% to $30.5 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $30.5 million, $47.0 million, and $35.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.